Day: June 24, 2025

SAN DIEGO, June 24, 2025 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that financial advisors Mike Trudeau, CFP®, Matt Merrick, Ben Ollila, CFP® and Ben Prchal have joined LPL Financial’s broker-dealer, Registered Investment Advisor (RIA) and custodial platforms, aligning with existing RIA firm Strategic Wealth Group. They reported serving approximately $220 million in advisory, brokerage and retirement plan assets* and join LPL from Thrivent Investment Management. Based just outside of Minneapolis in Lino Lakes, Minn., Trudeau, Merrick and Ollila began collaborating in 2009 and bring a combined three decades of financial industry experience to the practice. Prchal, who entered the financial industry in 2021, completes the team. Together, they take a take a holistic approach to helping their clients — most of whom are nearing...

SCOTTSDALE, Ariz., June 24, 2025 (GLOBE NEWSWIRE) — Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or the “Company”, “we”, or “our”), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug Administration (“FDA”) approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that the Company will join the small-cap Russell 2000® Index and the broad-market Russell 3000® Index, effective after the close of U.S. equity markets on June 27, 2025, as a result of their 2025 annual Russell Index reconstitution. “We are very pleased to be included in the Russell 2000® and Russell 3000® Indexes, which we anticipate will increase the company’s visibility with investors and institutions,” said Claude Maraoui, Journey Medical’s...

EMERYVILLE, Calif., June 24, 2025 (GLOBE NEWSWIRE) — National Mortgage Insurance Corporation (National MI), the primary operating subsidiary of NMI Holdings, Inc. (NASDAQ: NMIH), announced today it has received three prestigious company culture awards. National MI is proud to be recognized as a Great Place To Work® in 2025 and has also earned a “Decade of Great” distinction for garnering the honor ten consecutive years. Additionally, the company was ranked No. 22 among Fortune magazine’s Best Workplaces in the Bay Area. “We’re delighted to once again be recognized by Great Place to Work and even more proud to reach the ‘Decade of Great’ milestone based on the consistent feedback of our employees,” said Adam Pollitzer, President & CEO of National MI. “At National MI, we aim to lead with impact and a clear organizational mission,...

Mr. Cline brings extensive commercial expertise to lead the transition of Xenon to a commercial-stage company with the anticipated launch of azetukalner across three potential indications VANCOUVER, British Columbia and BOSTON, June 24, 2025 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced the appointment of Darren Cline as Chief Commercial Officer and member of the Xenon senior executive team. In this role, Mr. Cline will lead commercial strategy and operations for the Company’s portfolio of product and development candidates, with initial focus on its lead Phase 3 candidate, azetukalner, and first potential launch in epilepsy. Azetukalner is currently...

Enrollment is now underway across multiple clinical sites, in partnership with Syneos Health VANCOUVER, Washington, June 24, 2025 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today announced that the first patient has been dosed in the Company’s clinical trial evaluating the efficacy of leronlimab in patients with relapsed/refractory microsatellite stable colorectal cancer (“CRC”). In partnership with Syneos Health, the Company has engaged eight clinical sites and counting, and patient enrollment and processing efforts are underway. The lead principal investigator for the trial is Dr. Ben Weinberg, MD, from Georgetown University and the MedStar Health Alliance. According...

Navitas recognized for developing and delivering next-gen GaN and SiC technologies to support major automotive OEMs, including Volvo, ZEEKR, and SMARTVREMT Presents Navitas with ‘Outstanding Technical Collaboration Award’Navitas recognized for developing and delivering next-gen GaN and SiC technologies to support major automotive OEMs, including Volvo, ZEEKR, and SMART.TORRANCE, Calif., June 24, 2025 (GLOBE NEWSWIRE) — Navitas Semiconductor (Nasdaq: NVTS), the industry leader in next-generation GaNFast™ gallium nitride (GaN) and GeneSiC™ silicon carbide (SiC) power semiconductors, has been awarded the ‘Outstanding Technical Collaboration Award’ from VREMT Energy, a subsidiary of Geely, which specializes in new energy vehicle power batteries, electric drive systems, charging systems and energy storage systems. VREMT...

SUGAR LAND, Texas, June 24, 2025 (GLOBE NEWSWIRE) — CVR Partners, LP (NYSE: UAN) today announced that 2024 Schedule K-3s, reflecting items of international tax relevance, are now available online. Unitholders may access the information at www.taxpackagesupport.com/cvrpartners. A limited number of investors (primarily foreign unitholders, unitholders computing a foreign tax credit on their tax return and certain corporate and/or partnership unitholders) may need the detailed information disclosed on the Schedule K-3 for their specific reporting requirements. To the extent the Schedule K-3 is applicable to a unitholder’s federal income tax return filing needs, unitholders are encouraged to review the information contained on this form and refer to the appropriate federal laws or consult with their tax advisor. CVR Partners does not...

–During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study; on average, enobosarm 3mg significantly reduced body weight regain by 46% and completely prevented fat regain compared to placebo– –The enobosarm treated groups showed up to 93% greater fat loss and 100% lean mass preservation compared to the placebo group at the end of the study– –Enobosarm monotherapy had a positive safety profile with essentially no gastrointestinal side effects during the maintenance treatment period– — Based on efficacy and safety from Phase 2b QUALITY and Maintenance Extension study: —Enobosarm 3mg will advance as the proposed oral dose for the Phase 3 clinical program– –Veru...

VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) — BIGG Digital Assets Inc. (“BIGG” or the “Company”)(TSXV: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of TerraZero, Netcoins and Blockchain Intelligence Group, is pleased to announce that TerraZero Technologies’ Intraverse is redefining what it means to be an artist in the digital age. Today, the company announces a new wave of music activations across its immersive platform—each a milestone not just for the participating artists, but for the evolution of virtual experiences as a whole. The Company is seeing interest from all genres and artists. On the platform, you can find artists like FEELSOUL, a New Jersey songwriter, producer, rapper and poet. Among other unique elements, FEELSOULS’s experience has writings and musings...

London, United Kingdom, June 24, 2025 (GLOBE NEWSWIRE) — Blink Charging Co. (NASDAQ: BLNK) (“Blink”), a leading global owner, operator, provider, and manufacturer of electric vehicle (EV) charging equipment and services, has announced the promotion of Alex Calnan to the role of Managing Director of Europe. Calnan, who previously served as Managing Director of the UK, will now lead Blink’s efforts throughout the continent of Europe, including the United Kingdom, Ireland, Belgium, and the Netherlands, effective July 1, 2025. He will continue to be based out of Blink’s UK headquarters in St. Albans, Hertfordshire. He will be supported by Blink’s existing European leadership team. “We are confident that Alex is the right person to lead our European business, execute our strategy and selectively expand throughout Europe. He will bring...